<p>Get up to date with the latest EHA Clinical Practice Guidelines for Large B-cell lymphoma (LBCL) (<a href="https://onlinelibrary.wiley.com/doi/10.1002/hem3.70207">⁠<u>Large B‐cell lymphoma (LBCL): EHA Clinical Practice Guidelines for diagnosis, treatment, and follow‐up - Thieblemont - 2025 - HemaSphere - Wiley Online Library).</u>⁠</a> </p><p><br></p><p>Prof Catherine Thieblemont and Prof Marie José Kersten, two key authors of the guidelines,  walk us through the recommendations for Large B-cell lymphoma, covering diagnosis, treatment, and follow-up. </p><p><br></p><p>Gain insights into key diagnostic considerations including staging, biopsy techniques and the importance of molecular testing. Our guests explain treatment strategies for first-line and relapse/refractory patient populations, highlighting the practice-changing introduction of CAR T therapy in second-line for eligible patients. Finally, they discuss the disparities of access to innovative treatments across Europe and explore future perspectives of LBCL management in Europe and beyond. </p><p><br></p><p></p><p><br></p><p>Guests: Prof Catherine Thieblemont and Prof Marie José Kersten.  </p><p>Professor Catherine Thieblemont from Saint-Louis Hospital in Paris. </p><p>Professor Marie José Kersten from Amsterdam University Medical Centers (UMC) </p><p><br></p><p><strong>Learn More</strong></p><p><br></p><p>What did you think of this podcast? Share your opinions with us in this short feedback survey.</p><p><a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" target="_blank" rel="ugc noopener noreferrer">⁠⁠⁠⁠⁠Provide Feedback⁠⁠⁠⁠⁠</a></p><p><br></p><p>Would you like to explore more eLearning or podcasts? Please visit the EHA Campus.</p><p><a href="https://ehacampus.ehaweb.org/" target="_blank" rel="ugc noopener noreferrer">⁠⁠⁠⁠⁠https://ehaedu.org/Campus⁠⁠⁠⁠⁠</a></p><p><br></p><p>Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.</p><p>Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&utm_source=bcast&utm_campaign=eha-unplugged" target="_blank" rel="ugc noopener noreferrer">⁠⁠⁠⁠⁠https://www.instagram.com/EHA_Hematology/⁠⁠⁠⁠⁠</a></p><p>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&utm_source=bcast&utm_campaign=eha-unplugged" target="_blank" rel="ugc noopener noreferrer">⁠⁠⁠⁠⁠https://e-h-a.link/facebook⁠⁠⁠⁠⁠</a></p><p>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&utm_source=bcast&utm_campaign=eha-unplugged" target="_blank" rel="ugc noopener noreferrer">⁠⁠⁠⁠⁠https://www.linkedin.com/company/eha/⁠⁠⁠⁠⁠</a></p><p>Email us: [email protected]</p><p>Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&utm_source=bcast&utm_campaign=eha-unplugged" target="_blank" rel="ugc noopener noreferrer">⁠⁠⁠⁠⁠https://eha.news/subscribe⁠⁠⁠⁠⁠</a> </p>